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An epoch-making development in the gross anatomy of the lymph system has emerged:
the observation of the primo vascular system (PVS), which is a threadlike structure
floating in lymph ducts. The PVS, which was proposed as the conduit for the acupuncture
Qi, is a complex network distributed throughout an animal’s body. The lymph-PVS, which
is a subsystem of the PVS, is one of the most convincing visual demonstrations of the PVS.
Because its existence is not easily demonstrated, even with a microscope, due to its
transparency, in current anatomy its existence is largely unknown despite its potential
significance in physiology and medicine. The lymph-PVS has been observed in rabbits,
rats, and mice by several independent teams. Because the involved techniques are rather
complicated, we provide detailed protocols for surgery, for injection of the staining dye,
and for detection, extraction, and identification of the PVS in a rat.Institute of Convergence Technology, Seoul National University, Suwon 443-270, South Korea.
ong), kssoh1@gmail.com (K.-S. Soh).
to this work.
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The discovery of the specific marker LYVE-1 [1] was the
culmination of a series of investigations on lymphatic
endothelial cells that had been triggered by the discovery
of vascular endothelial growth factors [2,3]. For a long
time, the lymphatic system had only played an obscure role
as a second circulation system in addition to the blood
system. Then, its medical importance became prominent as
a key player in cancer metastasis [4] and as a major culprit
in inflammation due to the protein podoplanin and its
signaling molecule CCL21 [5].
In the current revolutionary period, another astounding
development in lymph research has appeared, the discov-
ery of a threadlike structure floating in lymph fluid, whose
existence had not been noticed previously due to its optical
transparency. It is a subsystem of the primo vascular system
(PVS), which was discovered by Bong-Han Kim in the early
1960s [6] and was hypothesized to be a third circulatory
system, an anatomical structure corresponding to the
acupuncture meridians, the classic Qi flowing path, but had
been ignored until its rediscovery by the Seoul National
University team [7] in 2002. Since 2002, there have been an
increasing number of reports on the PVS, which is composed
of threadlike structures called primo vessels (PVs), thick-
ened corpuscle-like parts called primo nodes (PNs), and a
fluid flowing in the vessels. The PVS has been observed in
various organs, such as the bloodstream [8,9], heart [10],
and brain [11], and on the surfaces of internal organs such
as the stomach, intestines, bladder, and liver [12,13]. The
animals studied most often were mice, rats, and rabbits,
and rarely pigs, dogs, and cows. The PVS has also been
found in adipose tissue [14], which is a source of pluripo-
tent stem cells [15].
With the aid of staining dyes, the presence of the PVS
has been impressively demonstrated as a threadlike struc-
ture floating in the lymphatic flow. It was observed in the
large-caliber lymph ducts near the caudal vena cava of a
rabbit by using the staining dye Janus green B [16] and in
those of a rat by using fluorescent nanoparticles [17] and
Alcian blue (AB) [18]. The PVS was observed in the thoracic
duct of a mouse without the use of a staining dye [19], and
other similar works on the PVS in lymphatic flow have
subsequently been reported [20e23].
One of the important investigations on the medical sig-
nificance of the PVS addressed the abundances in PNs of
immune cells, such as mast cells (20%), eosinophils (16%),
neutrophils (5%), histiocytes (53%), and a few lymphocytes
(1%). There were also round immature cells, which were
possibly stem cells (3%). Those stemlike cells showed some
positive signatures of hematopoietic stem cells [23] and
embryonic-like stem cells [24], which is in agreement with
the immune function augmentation by acupuncture [25].
Another medically significant finding was the possible impli-
cation of cancer metastasis through the PVS that developed
on the surface of a tumor [26e28]. The flowing fluids carried
hormones, such as adrenaline and noradrenaline [29], and
the flow speed was measured to be 0.3  0.1 mm/sec [30].
Although descriptions of the methods used in PVS ex-
periments have been given [16e23], those methods are not
easy to use and lack the detailed protocols necessary toobtain, for instance, PVS specimens for molecular-level
investigations to find vascular endothelial growth factors
and specific markers for the PVS. Here, we provide a
detailed protocol for surgery, dye injection, observation,
isolation, identification, and histological analysis of the PVS
in lymph ducts of a rat so that more researchers can
reproduce the experiments to elucidate the physiological
and the medical functions of the PVS.
2. Material and methods
2.1. Reagents
2.1.1. Experimental animals
Rats (SpragueeDawley, male, 9 weeks old, 280e300 g) were
purchased from DooYeol Laboratory Animal Company
(Seoul, Korea). The animals were housed in a constant
temperature-controlled environment (23 C) with 60%
relative humidity. All animals were exposed to a 12-hour
light-dark cycle and had ad libitum access to food and
water. Procedures involving animals and their care con-
formed to institutional guidelines (approval number:
WJIACUC 20130212-1-07), which were in full compliance
with current laws and policies [31].
2.1.2. Anesthesia
Zolatil (Virbac Laboratories, Carros, France) and xylazine
(Bayer, Korea).
2.1.3. PVS staining
Phosphate-buffered saline solution (PBS). 0.9% saline solu-
tion (Choongwae Pharmaceuticals, Korea).
2.1.4. AB staining
Alcian blue (AB) 8GX (Sigma, St. Louis, MO, USA), PBS pH 7.2
(1X; Life Technologies Corp., Grand Island, NY, USA).
2.1.5. Histology
Tissue-Tek optimal cutting temperature (OCT) freezing
compound (Sakura Finetek , Tokyo, Japan), base molds
(15 mm  15 mm  5 mm, Fischer Scientific, Waltham, MA,
USA), gel/mount medium (Biomeda Corp., Poster City, CA,
USA, no. M01).
2.1.6. DAPI staining
40,6-diamidino-2-phenylindole (DAPI; Invitrogen Molecular
Probes, Grand Island, NY, USA cat. no. D1306; 1:10,000).
2.1.7. Phalloidin staining
Alexa Fluor 488 Phalloidin (Invitrogen, Grand Island, NY,
USA).
2.1.8. DiI staining
1,10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanine
perchlorate (DiI; Sigma, St. Louis, MO, USA).
2.1.9. Hematoxylin and eosin (H&E)
Hematoxylin (Sigma, St. Louis, MO, USA), ethanol (Ducksan
Chemicals Co. Ltd, Korea), eosin (Sigma, St. Louis, MO,
USA), and xylene (Ducksan Chemicals Co, Ltd).
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NH4Fe(SO4)2 (Sigma, St. Louis, MO, USA), formaldehyde
solution (Duksan Chemicals Co. Ltd), AuCl4Na (Invitrogen,
Grand Island, NY, USA), KMnO4 (Fluka Chemical Corp,
Switzerland), AgNO3 (Kojima Chemicals Co, Ltd, Japan),
NaOH (Kanto Chemical Co. Inc., Japan), sodium thio-
sulphate (Sigma, St. Louis, MO, USA, Cas 7772-98-7), H2SO4
(Daejung Chemicals & Metals Co, Ltd, Korea), and neutral
red (CI 50040) (Sigma-Aldrich, Inc., St. Louis, MO, USA).
2.1.11. Immunohistochemistry
EMP-3: acetone (Ducksan Chemicals Co. Ltd) and CAS block
(Invitrogen, Grand Island, NY, USA, Cat. no. 008120). Anti-
bodies: (EMP-3), primary: rabbit anti-EMP3 (Santa Cruz
Biotechnology (Dallas, Texas, USA, Cat. no. sc-135143)),
and secondary: goat antimouse AlexFluor 568 (Invitrogen
Molecular Probes, Grand Island, NY, USA, Cat. no. A11034).
vWF: bovine serum albumin (BSA) (Biotechnology, Canada)
and triton x-100 (Shino Pure Chemicals Co, Ltd, Japan).
Antibodies: (vWF), primary: mouse anti-vWF (Santa Cruz
Biotechnology, Dallas, Texas, USA, cat. no. sc-365712) and
secondary: goat antirabbit AlexFluor 488 (Invitrogen Mo-
lecular Probes, Grand Island, NY, USA, Cat. no. A11037).
2.2. Equipment
Microscopes and light source Stereomicroscope (SZX12,
Olympus, Japan) with a charge-coupled device (CCD)
camera (DP70, Olympus), phase-contrast microscope
(BX51, Olympus) with a CCD camera (Infinity 3, Lumenera),
confocal laser scanning microscope (CQ plus, Nikon,
Japan). Light source and optical fiber illuminator (Halogen
lamp, KLS-100H-LS-150P, Kwangwoo Co, Ltd, Korea).
2.2.1. Surgical instruments
Surgical instruments and ophthalmic surgical instruments
(Tumed, German; see for details equipment setup in the
supplementary material online). Electric surgical unit
(Surgitor, Korea), electrocautery (Umeco, Korea). Dispos-
able Gentax latex glove (Geneall Biotechnology, Korea), Pet
Specialty cordless trimmer (Oster, USA), masking tape
(Scitech Korea Inc., Korea), gauze (Scitech Korea Inc.),
surgical drapes (Scitech Korea Inc.), electric heating pad
(size: 30 mm  30 cm; Woojin Tech, Korea).
2.2.2. Syringes and filters
Hypodermic syringe (Kovax- Syringe, Korea), BD ultrafine in-
sulin syringe,31G (Becton,DickinsonCompany, Franklin Lakes,
NJ,USA), BD5-mlfilter syringe (BectonDickinsonMedicals Ltd,
Singapore), BD 10-mLfilter syringe (BectonDickinsonMedicals
Ltd, Singapore). Glass microfibre filters 110 mm (GE Health-
care Co., UK, cat. no. 1820-110), minisart syringe filter, and
hydrophilic (Sartoriou Stedim Biotech, Germany).
2.2.3. Staining and histology instruments
pHmeter (ThermoElectronCorporation,Waltham,MA,USA),
glass funnel (Dongsung Science, Korea), round bottom test
tube, 5 mL (BD Falcon, San Jose, CA, USA), coplin jar (Fisher
Scientific, Waltham, MA, USA), pap pen (Invitrogen, Grand
Island, NY, USA), and Vortex-2 Genie (Scientific Industries,
Bohemia, NewYork, USA). 5e10-mL finnpipette (Lab Systems,Korea) and disposable transfer pipette (Lappia, Korea).
Microslides (silane coating; size: 76 mm  26 mm; Mutopure
Chemicals Co, Ltd, Japan), 100 deckglaser coverslips (size:
24 mm 50 mm; Knittel Glass, Germany), and Leica CM1800
cryostat (Leica, Germany).
2.3. Reagent setup
2.3.1. Animals
Sprague-Dawley (SD) rats (260e300 g, 9 weeks old) were
used. Males are preferred because they develop less
abdominal fat, making the surgery easier.
2.3.2. PBS solution
Eight g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, 0.24 g of
KH2PO4, and 800 mL of distilled water are mixed together to
make a solution, and using a pH meter, the pH is set to 7.4.
An additional 200 mL of distilled water is added to the
previously mixed solution to make 1 L (1000 mL) of 1 PBS
solution, which is stored at room temperature.
2.3.3. Alcian blue (AB) staining dye (1.0%)
Combine 0.01 g of AB powder with 1 mL of 1 PBS solution to
make 1%AB staining dye. Aftermixing these, apply the vortex
machine andput this solution in theheating cabinet (w 61 C)
for about 30 minutes to dissolve the AB powder completely.
Filter this solution with a filter paper in a funnel first, fol-
lowed by a second filtration using a 0.20-mm syringe filter
attached in a 10-mL syringe. After the second filtration, load
theAB solution in a 1-mL insulin syringe (31 gauge)while using
awarmbath to keep it at a constant temperature of 38e40 C
prior to injection into the lymphatic system.
2.3.4. Preparation of the DAPI stock solution
To make a 5 mg/mL DAPI stock solution (14.3 mM), dissolve
the contents of one vial (10 mg) in 2 mL of deionized water
or dimethylformamide (DMF). Note: DAPI is not very soluble
in PBS.
For long-term storage, the stock solution can be ali-
quoted and stored at less than 20 C. For short- term
storage, the solution can be kept at 2e6 C, protected from
light. When handled properly, DAPI solutions are stable for
at least 6 months.
2.3.5. Preparation of the DAPI working solution
Dilute the DAPI stock solution to 300 nM in PBS. Add
approximately 300 mL of this dilute DAPI staining solution.
2.3.6. Phalloidin
Combine 10 mL of 6.6-mM Alexa Fluor 488 phalloidin and
300 mL of PBS. Use the sonicator to mix these well and store
the solution at 20 C. Avoid exposure to light.
2.3.7. DiI solution
(1) Prepare EtOH stock solutions: The stock solutions
should be prepared in EtOH at 1e5 mM. A stock dye
solution containing 2 mg/mL DiI in dimethyl formamide
can be stored at 20 C in a tube wrapped in foil. Note:
The unused portion of the stock solution should be
stored at 20 C. Avoid repeated freeze/thaw cycles.
CAUTION: Carcinogen.
(6) 0.2% Gold chloride:
Gold chloride (Sodium tetrachloroaurate, BDH) ---- 0.2 g
Distilled water ----------------------------------------- 100 mL
Rinse the entire contents of bottle of gold chloride (sodium chloroaurate) into an acid-
clean glass bottle. Store in the refrigerator; stable for 1 year.
CAUTION: Avoid contact and inhalation.
(7) 2% Sodium thiosulfate:
Sodium thiosulfate ----------------------------- 0.2 g
Distilled water ---------------------------------- 10 mL
Store in the refrigerator; stable for 3 months.
(8) Neutral Red Stain – acidified:
Neutral red (CI 50040) -------------------------- 1 g
Distilled water ----------------------------------- 100 mL
gl acetic acid ------------------------------------- 1 mL
Dissolve the dye in the distilled water. Add the acid. Mix well. Filter into the reagent 
bottle. Keeps well. Stable for 1 year.
CAUTION: Irritant; avoid contact with skin and inhalation.
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into 1 mL 100% EtOH (1:200 dilution) to make 1e5 M
working solutions. Wrap in foil and incubate on a slow
shaker for 3 hours overnight.
2.3.8. Harris’ H&E
(1) Acid alcohol solution (1%): Mix well 1 mL of hydrochloric
acid and 50 mL of 70% ethanol.
(2) Ammonia water solution (0.2%): Mix well 2 mL of ammo-
nium hydroxide (concentrated) and 1000 mL distilled
water.
(3) Eosin-Phloxine B solution: Prepare the stock solutions
first, and then create the working solution as needed.
(4) Eosin stock solution: Mix to dissolve 1 g Eosin Y and
100 mL distilled water.
(5) Phloxine stock solution: Mix to dissolve 1 g Phloxine B
and 100 mL distilled water.
(6) Eosin-Phloxine B working solution: Mix well 100 mL
Eosin stock solution, 10 mL Phloxine stock solution,
780 ml 95% ethanol, and 4 mL glacial acetic acid.
(7) Hematoxylin solution (Harris): Mix well 100 g of potas-
sium or ammonium (alum) and 1000 mL distilled water.
Heat to dissolve. Add 50 mL of 10% alcoholic hema-
toxylin solution and heat to boil for 1 minute. Remove
from heat and slowly add 2.5 g of mercuric oxide (red).
(i) Heat to the solution and until it becomes dark pur-
ple in color.
(ii) Cool the solution in a cold water bath and add 20 mL
of glacial acetic acid (concentrated).
(iii) Filter.Gordon & Sweet’s silver staining
(1) Acidified potassium permanganate XE: Potassium permanganate:acidified:
0.5% Potassium permanganate ---------- 9.5 mL
3% Sulfuric acid -------------------------- 0.048 mL
Make fresh, discard after use.
CAUTION: Corrosive; avoid contact and inhalation
(2) Silver solution: To 5 mL of 10% aqueous silver nitrate, add strong ammonia drop by 
drop until the precipitate that was first formed is just dissolved. Add 5 mL of 3% sodium 
hydroxide, then add strong ammonia drop by drop until the resulting precipitate is almost 
completely dissolved. Make up to 50 mL with distilled water and pour into a clean coplin 
jar.
CRITICAL STEP!
If too much ammonia is added there is a great loss of sensitivity.
CAUTION: Corrosive; possible carcinogen.
(3) 2% aqueous oxalic acid:
Oxalic acid (analytical) ------------------ 0.2 g
Distilled water --------------------------- 10 mL
Mix well, label with initial and date. Solution is stable for 1 year.
CAUTION: Corrosive; avoid contact and inhalation.
(4) 4% aqueous iron alum:
Iron alum (Ferric ammonium sulfate) ---0.4 g
Distilled water --------------------------------- 10 mL
Mix well, label with date, and initial. Solution is stable for 6 months.
(5) 10% Formalin:
Formaldehyde (Ajax, 37–40 g/L) ----------- 1 mL
Distilled water --------------------------------- 9 mL
Make fresh; discard after use.2.3.9. EMP-3
(1) Primary antibody: Dilute the primary antibody in freshly
prepared CAS blocking solution to reach 1:200 ratio. Mix
well 1 mL primary antibody to 200 mL in blocking solu-
tion. A 0.5-mL tube requires 200 mL of diluted antibody.
Diluted primary antibodies can be reused up to three
times. Some antibodies may last even longer. Store
antibodies between uses at 4 C for no more than 1
month.
CRITICAL STEP!
As little as 200 mL of diluted antibody can be used in a
0.5-mL tube when quantities of antibodies are very
limited.
(2) Secondary antibody: Dilute the secondary antibody in
freshly prepared 1 PBS solution down to 1:500. Mix
well 0.4 mL secondary antibody to 500 mL in 1 PBS
solution. A 0.5-mL tube requires 200 mL of diluted
antibody. Prepare fresh and discard secondary anti-
bodies after use.
CRITICAL STEP!
As little as 200 mL of diluted antibody can be used in a
0.5-mL tube when quantities of antibodies are very
limited.
2.3.10. vWF
(1) Primary antibody: Dilute the primary antibody in freshly
prepared 1% BSA blocking solution to reach 1:50 ratio.
Mix well 4 mL primary antibody to 200 mL in blocking
solution. Diluted primary antibodies can be reused up
to two times. Store antibodies between uses at 4 C for
no more than 1 month.
(2) Secondary antibody: Dilute the secondary antibody in
freshly prepared 1 PBS solution down to 1:100. Mix
well 2 mL secondary antibody to 200 mL in 1 PBS so-
lution. A 0.5-mL tube requires 200 mL of diluted
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bodies after use.Surgical procedure set-up notes:
- Prior to the surgery sterilize surgical supplies and
instruments.
- Supplies include one drape to be laid out as a
sterile surface for the placement of instruments
and another drape with a pre-cut hole about
1.5 cm  3 cm in the center to be placed over the
rat. The precut hole on the drape will show the
incision to be made on the rat.
- Instruments include one standard pair of scissors
to be used to cut suture material, two forceps and
a fine needle holder for handling and gripping of
the suture, and a scalpel with a blade.
- Preheat pH 7.4 PBS and AB solution loaded in a
syringe to 39 C.2.3.11. IHC blocking solution
Prepare 1% (wt/vol) BSA, 0.5% (vol/vol) Triton X-100 in PBS.
Prepare fresh each time of use.
2.4. Equipment setup
Two large scissors, a small microscissors, two large forceps,
two microdissecting tweezers, small forceps, one pair of
fine straight forceps, one pair of curved forceps, one micro-
dissecting straight forceps, one pair of angular micro-
dissecting forceps, and one 31 G insulin syringe (Fig. 1).
CRITICAL STEPS!
All instruments and other equipments must be sterilized
prior to use.
In addition to sterile microdissecting instruments, two
sets of sterile instruments should be used. Separate sets are
used for the skin and for the peritoneal wall and for
dissection and extraction of the primo system in the lymph
vessels to reduce the chances of contamination while pro-
ceeding through the tissue layers.
3. Procedure
An overview of the entire procedure. Steps 1e4: Preparing the animal prior to surgical
operation.
 Steps 5e16: Detecting the PVS network.
 Steps 17e18: Harvesting the PVS.
 Steps 19e22: Analyzing the PVS.
 Steps after 22: Identifying the PVS.3.1. Animal preparation (35e45 minutes)
(1) The rats should fast for 48 hours to reduce fats in
order to obtain a clear view of the lymphatic system
in fat tissues, which contain many blood capillaries
and cover the abdominal organs. Avoidance of
bleeding during the surgery and precise injection
of AB are critical factors for which lean rats are
needed.
(2) Anesthetize the rat with an intramuscular injection of a
mixture of zolatil (0.3 mL) and xylazine (0.1 mL) by
using a 1-mL hypodermic syringe.
(3) Shave the abdominal skin by using the Pet Specialty
cordless trimmer (Oster). Fix the rat with its head away
from the operator by taping its feet to the operating
table. Cover the rat’s eyes with gauze to prevent
exposure to light.
(4) Position the fiber optic illuminators for optimum illu-
mination. Adjust the stereomicroscope and monitoring
system for optimal observation.3.2. Surgical procedures and observation (3e5
hours)3.3. Laparectomy
CAUTION!
Fine dissecting techniques are needed so as not to
damage blood vessels and other fine structures. Aseptic
consideration: Wear sterile gloves and do not allow in-
struments and supplies to contact nonsterile surfaces other
than rat tissues.
(5) Position the anesthetized rat on its back on a heating
pad to maintain body temperature. In order to disinfect
the abdominal skin, wipe the skin with a cotton-tipped
applicator and aseptic tissue paper soaked in 70% (v/v)
ethanol.
(6) Grip the middle skin of the abdomen with toothed for-
ceps, and incise the outermost skin along the middle line
(linea alba line) down to the symphysis pubis andup to the
ensisternum with surgical scissors. The depth of incision
should just be shallow enough to see the muscular layer.
(7) Hold the abdominal muscle upward and make a small
slit along the linea alba in the straight muscle of the
abdomen at the place of the lower third on the line
from the ensisternum to the symphysis pubis by using
small scissors. Insert the scissors into the slit and cut
the abdominal muscle along the linea alba to the xi-
phoid process. Avoid bleeding during this cutting. The
incision must be on or around the linea alba because
the distribution of blood vessels is the least in this area.
Do not insert the scissors too deeply into the peritoneal
cavity and keep the tip of scissors pointed upward in
order not to damage the underlying structures.
3.4. Locating lumbar nodes
(8) Gently move the intestines to the animal’s right side in
order to expose the area of the caudal vena cava and
Figure 1 Arrangement of the experimental system. (A) Box
diagram of the modules of the system. (B) A photograph of an
arrangement.
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saline solution over the gauze to avoid dryness.
(9) Under the stereomicroscope expose a lumbar lymph
node by removal of adipose tissues with curved forceps.
Grasp the node and tease away the surrounding con-
nective tissues with a cotton bud prior to AB injection
into the node. Use a disposable transfer pipette to add
warm saline solution drop by drop over the lymphatic
vessel to avoid dryness.
CRITICAL STEPS!
Find the caudal vena cava first and search around it for
lumbar lymph nodes. Sometimes, depending on the rats,
the lymph systems are covered with thick adipose tissues
and layers of membranes. In such a case, remove these
membranes and adipose tissues to secure a clear view of
the lymph systems.Use curved forceps and a cotton bud in order to expose the
chain of lymph nodes located along the caudal vena cava.
Usually there are two ormore small nodes at the lumbar lymph
nodeposition.Foraccurate injection, choose the largestnode.
Damage to large blood vessels must be avoided. If
necessary, maintain hemostasis by pressing the vessels with
a cotton bud. In the case of massive bleeding, use elec-
trocautery to stop bleeding. Because many small blood
vessels are spread throughout the adipose tissues, a cotton
swap is recommended for their removal).
3.5. Visualization of the PVS
(10) Inject a small amount (0.1e0.2 mL on each side) of pre-
loaded 1% AB solution, preheated to 37 C in awarm bath,
into the lumbar node, both sides, by using a 31-gauge ul-
trafine insulin syringe. Injecting the dye at a slow rate is
essential; otherwise, it will leak out and stain the sur-
rounding area. After injection the original transparent
lymph ducts (Fig. 2A) will become blue-colored due to the
ABflowupward along the lymphfluid (Fig. 2B). TheABwill
also stain many small branches of the lymph ducts. Drop
warmsalineoftenon the lymphaticducts toavoiddryness.
CAUTION!
Keep air out of the syringe at the beginning of the in-
jection and insert the needle at an angle of less than 40 C
relative to the lymph nodes. Wait several minutes after
inserting the needle until the node becomes stabilized.
In order to avoid AB precipitation when it is dissolved in
1 PBS, store the solution in an oven (68e75 C) for 10
minutes prior to use.
If blood vessels in the lumbar node are damaged during
injection of AB, bleeding will occur and blood will coagu-
late with the PVs, causing a thickening of PVs due to the
adhered blood cells.
(11) In order to enhance the lymph flow for efficient washing
of AB, replace the moved internal organs to their orig-
inal positions, close the outermost skin, and cover the
rat’s body with tissue paper three to four times to
maintain body temperature. Put the rat on its back on a
heating pad. Warming the rat with infrared light is to be
avoided. Let the rat sit for 60e120minutes for sufficient
washing so that the lymph ducts become clear again
(Fig. 2C) and the PVS emerges as a floating blue
threadlike structure (Fig. 2C). This is the essence of the
visualizing technique of the current protocol.
3.6. Observation of the PVS
(12) Open the abdomen and again move the internal organs
to the side, and repeat Step 8.
(13) Take a close look at the lymph vessels with the ste-
reomicroscope to detect the PVS and trace it up to the
cisterna chyli near the diaphragm. The PVS forms a
network in the complex web of lymph vessels and
often passes through lymph valves (Fig. 3A and B).
CRITICAL STEPS!
A fine operation is required to avoid bleeding when
tracing the PVS due to tangling of the blood vessels in the
complicated structures of membranes and fats.
Figure 2 Stereomicroscopic images of the lymph ducts (double arrows) and primo vessels in them. (A) Transparent lymph
ducts beside the caudal vena cava (CVC) prior to AB injection. (B) The same lymph ducts blue colored immediately after
AB injection. (C) The lymph ducts washed for 2 hours by lymph flow. The lymph ducts became transparent and thin a blue
color PVS emerged in the ducts. (D) A schematic diagram showing the locations of the major lymph ducts and lymph nodes
around the large abdominal veins and arteries. (E) The net of the PV appeared as blue thin curves in the lymph ducts after
washing.
312 S.J. Jung et al.Large lymph ducts are located regularly, but small
lymphatic vessels are distributed irregularly. Considering
this point, search for as many of them as possible in order
not to miss the PVS in them.
(14) Euthanize the rat by using an intracardiac injection of
0.7 mL (3.2 g/kg) urethane to search further for the
PVS in the thoracic cavity. Check the rat’s vital signs to
confirm the euthanasia.
(15) Open the diaphragm and note the lymphatic system’s
connection between the thorax and the abdomen. Cut
the rib cage and pin the ribs outwardly open. The su-
perior vena cava can be located by lifting the heart
and separating the lobes of the lung. The thoracic duct
is a thin transparent tube just beside the right-hand
side of the superior vena cava.
(16) Search for the blue, thin, threadlike PVS floating inside
the thoracic duct (Fig. 3 and Movie I in supplementary
material online).Supplementary data related to this article can be found
at http://dx.doi.org/10.1016/j.jams.2013.09.001.3.7. PVS tissue harvest (1 hour)
(17) With microscissors, cut the lymph vessels that contain
the PVS and put the specimen on a slide (Fig. 4A).
Incise the lymph vessel longitudinally by using micro-
scissors, pick up the PVS with microforceps, pull it out
toward the body gently, and put it on a glass slide.
CRITICAL STEPS!
Tear the lower end of a harvested lymph vessel with
sharp-end forceps and expose the end part of the PVS in it.
Pull the PV gently out.
On-site checklist for identification of the PVS from ar-
tifacts such as coagulation of AB with lymph fluids in a
stringlike form: (1) It is a floating threadlike structure not
attached to the lymph walls. (2) The PVS thread is elastic
but the AB coagulation is not and is, therefore, easily
Figure 3 Stereomicroscopic images of the PVS in lymph
ducts. (A) Branching of a PV along the branching of a lymph
duct (double arrow). There was a PN in one branch. (B) A PV
passing through a lymph valve which showed two sides stained
blue. (C) A lymph node with four afferent ducts which com-
bined into a duct. In each branch there was a PV. Each of the
intermediary two ducts had a PN.
Figure 4 Images of a harvested primo vessel (PV). (A) A PV in
a lymph duct on a slide. In the right inset is the extracted PV.
(B) Phase contrast microscopic image of the PV. (C) DAPI
stained rod-shaped nuclei (arrows) and phalloidin stained
f-actins are aligned along the PV. The PN was packed with
nuclei.
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20e30 mm. (4) The PNs are thicker parts of the PV, and their
numbers, thicknesses, and lengths vary. (5) The PVs pass
through lymph valves. (6) The PVs branch at the branching
of the lymph vessels. (7) If the thickness of a PV is larger
than 50 mm, the PV most likely has adhered blood cells or
lymphocytes.
(18) Fix the PVS specimens isolated from the lymph vessels
with either 4% paraformaldehyde solution or 10%
neutral buffered formalin solution and store them for
1e2 Days at 4 C in a refrigerator for further analysis.
CAUTION!
Formalin fixation will inactivate infectious agents.
However, it is recommended that universal precautions are
followed when working with formalin-fixed tissues.
Troubleshooting
(1) Sometimes confounding fake stringlike tissues
appeared. We recommend that the DAPI-test be
applied to the putative PV-specimens because the
characteristic distribution of the rod-shaped
nuclei is a good criterion to discern the PV from
other string-like tissues.
(2) As some stains might be dim, picture taking
immediately after staining is recommended.
Avoid light exposure of stained tissues at all
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3.8.1. Analysis with Dapi and Phallodin (40 minutes)
(19) Wash the fixed samples with 1 PBS solution two or
three times. Pay attention to and keep the branches of
the PV well. Put either the fresh or the fixed PV sample
on a glass slide with one to two drops of PBS 1 solu-
tion. Wash the samples in PBS, place them on slides,
and under a microscope, slightly flatten the tissues for
examination.
(20) In order to show the f-actins in the endothelial cells of
the PV, stain the specimen with 6.6-mM phalloidin for
20 minutes, followed by three-time PBS washes.
(21) Stain the same specimen with Prolong Gold Antifade
(Life Technologies Corp., Grand Island, NY, USA, Cat.
no P36931) reagent with DAPI again for 10 minutes to
examine the nuclei in the endothelial cells of the PV.
When you apply DAPI, mix thoroughly, but take care
not to create too many bubbles. Drain excess solution
from the slide. Apply two separate drops of Gel Mount
e DAPI on the sections, and lower the cover slip on the
sections. Let the slide be in darkness for a few mi-
nutes, and seal the cover slip with a transparent
manicure.
CAUTION!
Avoid light on the sample during the phalloidin and DAPI
staining procedures.
(22) Examine the specimens with a fluorescence phase
contrast microscope (Olympus BX51, Olympus) and a
confocal laser scanning microscope (CLSM; C1 plus,
Nikon) to observe f-actins and the rod-shaped nuclei
(Fig. 4C).
CRITICAL!
Morphological characteristics of the PV are thickness
(20e30 mm), bundle structure of several subvessels, rod-
shaped nuclei (length: 15e20 mm) of endothelial cells
aligned in the broken parallel curves, and sometimes
presence of DNA-containing granules inside subvessels.
F-actins are also aligned along the PV.
Nonpure, thick samples have coagulated lymphocytes
surrounding the PV.
3.9. Histology and immunostaining (2e3 days)
Because the procedures in this stage are conventional ones
we put them in supplementary material online.
(23) Preparation of tissue specimens A lymph duct with a
PV inside was prepared for the cross-sectional exami-
nation. Place the tissue sections in base molds, cover
with OCT compound, and wrap frozen OCT-tissue
blocks with aluminum paper. Quench the specimen in
liquid nitrogen and store at 80 C until use for
sectioning.
(24) Sectioning.
(25) Fixation and sample preparation.
(26) Histology H&E; DiI; Gordon & Sweet’s Silver Stain-
ing.(27) Immunohistochemistry EMP-3; vWF.
CRITICAL!The histological characteristics of the PV provide the
proof for the claim that the PVS inside a lymph duct is a
genuine new tissue rather than an artifact. H&E shows
the nuclei and the cytoplasm in this tissue. DiI shows the
surrounding membrane, which proves independent struc-
ture separate from the lymph ducts. Coagulation or
aggregated lymphocytes or fibrins do not have a wrapping
membrane. Silver staining shows the presence of reticular
fibers whereas the inner wall of the lymph vessel does
not have such fibers. EMP-3 positive expression shows
that the PV has epithelial cells at the exterior side, and
vWF positive expression shows the presence of endothe-
lial cells, which is consistent with the rod-shaped nuclei
in the PV.
Further evidence of the wrapping membrane with elec-
tron microscope was reported earlier [17], and was further
confirmed with atomic force microscopy data (not shown).
The negative expressions of the PV in earlier works against
both of CD34 and LYVE-1 clearly showed that the PVS is
different from blood or lymph vessels.3.10. Time distribution during the entire
procedure
 Steps 1e4: Preparing the animal prior to operation
(timing: 35e45 minutes).
 Steps 05e16: Detecting the PVS network (timing: 3e5
hours).
 Steps 17e18: Harvesting the PVS (timing: 1 hour).
 Steps 19e22: Analyzing the PVS (timing: 40 minutes).
 Steps after 22: Identifying the PVS (timing: 2e3 days).
times.3.11. Anticipated results
3.11.1. Anatomy
The network of lymph ducts near the caudal vena cava and
the thoracic duct of a rat are the target of the search for
the PVS (Fig. 2). The PVS forms a network of blue, thin,
threadlike structures stained with AB in lymph ducts of
various thicknesses. A PV passes through lymph valves and
forms branches where lymph ducts branch (Fig. 3B).
3.11.2. Identification
A floating, blue, threadlike structure should be tested for
its elasticity (see Movie I in the supplementary material
online) so as not to confuse it with an artifact temporarily
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crushed to pieces by shaking the lymph duct. A PV is elastic,
which can be sensed when it is extracted from the lymph
duct ex vivo on a slide. The thickness is about 20e30 mm. If
it is thicker than 50 mm, it is most likely enshrouded with
lymphocytes and fibrin. This coagulation is due to bleeding
in the lymph node during injection. A PV is a bundle of
several subvessels. This bundle structure is a key feature ofFigure 5 Histological analysis of the PVS in lymph ducts. (A and B)
boundary is indicated with a dotted curve) in a lymph duct (inner b
boxed area. (C and D) Longitudinal section of the same specimen.
duct (arrowheads) (E) The DiI stained PV (arrows) was flanked by the
the outer boundary which showed that it was wrapped by a memba PV that uniquely distinguishes it from blood or lymph
vessels. The thickness of a PV is fairly uniform except at the
PNs. The presence of PNs along a PV is irregular, and their
sizes and shapes also vary. They can be recognized as the
cucumber-shaped thick parts of a PV.
The PVS can be identified positively by observing the
distribution of nuclei in the longitudinal sections to distin-
guish the PVS from blood or lymph vessels. The nuclei of theCross section images of a hematoxylin and eosin-stained PV (its
oundary is indicated with arrows) and its magnified view of the
The PV is indicated with arrows and surrounded by the lymph
lymph duct (arrowheads). The PV showed positive DiI signals at
rane. Nuclei are stained blue with DAPI.
Figure 6 Immunohistochemical analysis of PV and PN which shows a positive expression to the vWF and EMP-3. (A, B, and C)
Cross-sectional images of a PV (arrow) inside a lymph duct. They are DIC, vWF, and EMP-3 images, respectively. (D, E, and F)
Longitudinal images of the same PV (arrows) flanked by the lymph duct, in the same order. (G and H) Positive expression of a PN
(arrow) in a lymph duct (arrowhead) to EMP-3 and its phase contrast image, respectively. (I) Gordon & Sweet’s silver staining of the
PN (arrow) shows a presence of reticular fibers. (J) DiI of a PN shows a positive expression of the boundary (arrow). The lymph duct
(arrowhead) shows a much stronger signal which is a positive control.
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broken parallel lines, and they are rod-shaped, about
10e20 mm in length. This feature can be easily checked
with DAPI staining with confocal images (Fig. 4C). These
rod-shaped nuclei are thought to be the endothelial cells
lining the subvessels. The endothelial nature of these cells
has only been proved based on the vWF criterion and has
not yet been confirmed by using other characteristics.
Development of antibodies such as LYVE-1 will be a critical
step toward a complete tracing of the entire network of the
PVS.
3.11.3. Histological analysis
For the PVS identification, histological and immunohisto-
logical analysis should follow. DiI staining shows the outer
membrane of a PV and a PN, H&E staining shows the dis-
tribution of cells and nuclei, and silver staining shows the
reticular fibers (Fig. 5).
Immunostaining with EMP-3 reveals that the outer parts
of the PVS are made of epithelial cells, whereas vWF
staining shows that the inner cells have an endothelial na-
ture (Fig. 6).
3.12. Further research
Establishing a protocol for lymph-PVS is the first step to-
ward full elucidation of this new circulatory system. First,
finding the vascular endothelial growth factors and the
specific markers corresponding to LYVE-1 will be a mile-
stone for molecular-level research on the PVS, and fully
tracing the PVS network will reveal its connection with
other parts of the PVS like those on the surfaces of internal
organs [13], in the heart [10], and the blood vessels [8, 9].
The abundance of immune cells, such as histiocytes and
mast cells in a PN, was already studied. A PN might be a
niche for hematopoietic stem cells [23]. The PN associated
with a xenografted tumor may provide a safe haven for a
select population of cancer stem cells [28] whereas the PV
is an additional metastasis path for cancer cells [27].
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